A tissue cage model in calves for studies on pharmacokinetic/pharmacodynamic interactions of antimicrobials

Christina Greko1, Maria Finn, Patrik Ohagen

  • 1Department of Antibiotics, National Veterinary Institute (SVA), SE-75189 Uppsala, Sweden. christina.greko@sva.se

Insights

A novel in vivo model using tissue cages in calves was developed to study antimicrobial pharmacokinetic/pharmacodynamic (PK/PD) interactions. This model effectively simulated drug concentration-time profiles to assess infection treatment outcomes.

Area of Science:

  • Veterinary Medicine
  • Pharmacology
  • Infectious Diseases

Background:

  • Understanding antimicrobial pharmacokinetic/pharmacodynamic (PK/PD) interactions is crucial for effective treatment strategies.
  • Existing in vivo models may not fully replicate complex in-body drug dynamics and infection responses.

Purpose of the Study:

  • To develop and validate a novel in vivo model for investigating PK/PD interactions of antimicrobials.
  • To evaluate the predictive value of different PK/PD indices for antimicrobial efficacy in an established infection model.

Main Methods:

  • An in vivo model was established in calves using implanted tissue cages of varying volumes.
  • Infection was induced with Mannheimia haemolytica, and penicillin was administered directly into the cages.
  • Different antimicrobial concentration-time profiles were simulated to monitor infection response.

Main Results:

  • The model successfully simulated diverse PK/PD profiles and allowed for monitoring of infection effects.
  • Area under the curve to minimum inhibitory concentration (AUC/MIC) and time above MIC were found to be equally predictive of antimicrobial effect.
  • Cmax to MIC ratio was not a reliable predictor of treatment success in this model.

Conclusions:

  • The developed tissue cage model provides a valuable platform for studying antimicrobial PK/PD interactions in vivo.
  • AUC/MIC and time above MIC are key PK/PD indices for optimizing penicillin dosage against Mannheimia haemolytica infections.
  • This model offers an alternative approach for exploring drug dosage optimization strategies in veterinary medicine.

Related Concept Videos

Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...